Low dialysate potassium and central arterial pressure waveform

References

• Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–69.
   PubMed Web of Science ®Google Scholar
• Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet. 2003;361:2024–31.
   PubMed Web of Science ®Google Scholar
• Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–48.
   PubMed Web of Science ®Google Scholar
• Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395–407.
   PubMed Web of Science ®Google Scholar
• Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377:2181–92.
   PubMed Web of Science ®Google Scholar
• EVOLVE Trial Investigators. Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012;367:2482–94.
   PubMed Web of Science ®Google Scholar
• Ostermann M. Cardiac arrests in hemodialysis patients: an ongoing challenge. Kidney Int. 2008;73:907–8.
   PubMed Web of Science ®Google Scholar
• Weisberg LS, Rachoin JS. The safety of low-potassium dialysis. Semin Dial. 2010;23:556–60.
   PubMed Web of Science ®Google Scholar
• London G, Guerin A, Pannier B, Marchais S, Benetos A, Safar M. Increased systolic pressure in chronic uremia. Role of arterial wave reflections. Hypertension. 1992;20:10–19.
   PubMed Web of Science ®Google Scholar
• Joannides R, Bakkali EH, Le Roy F, Rivault O, Godin M, Moore N, et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant. 1997;12:2623–8.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865–71.
   PubMed Web of Science ®Google Scholar
• Mardare NG, Goldsmith DJ, Gusbeth-Tatomir P, Covic A. Intradialytic changes in reflective properties of the arterial system during a single hemodialysis session. Hemodial Int. 2005;9:376–82.
   PubMedGoogle Scholar
• Covic A, Goldsmith DJ, Panaghiu L, Covic M, Sedor J. Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms. Kidney Int. 2000;57:2634–43.
   PubMed Web of Science ®Google Scholar
• Cross JM, Donald A, Vallance PJ, Deanfield JE, Woolfson RG, MacAllister RJ. Dialysis improves endothelial function in humans. Nephrol Dial Transplant. 2001;16:1823–9.
   PubMed Web of Science ®Google Scholar
• Soveri I, Lind L, Wikstrom B, Zilmer M, Zilmer K, Fellstrom B. Improvement in central arterial pressure waveform during hemodialysis is related to a reduction in asymmetric dimethylarginine (ADMA) levels. Nephron Clin Pract. 2007;106:c180–6.
   PubMed Web of Science ®Google Scholar
• Georgianos PI, Sarafidis PA, Malindretos P, Nikolaidis P, Lasaridis AN. Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients. Am J Nephrol. 2011;34:407–14.
   PubMed Web of Science ®Google Scholar
• Gabutti L, Salvade I, Lucchini B, Soldini D, Burnier M. Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids. BMC Nephrol. 2011;12:14.
   PubMedGoogle Scholar
• O’Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens Suppl. 1996;14:S147–57.
   PubMedGoogle Scholar
• Savage MT, Ferro CJ, Pinder SJ, Tomson CR. Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Lond). 2002;103:59–65.
   PubMed Web of Science ®Google Scholar
• O’Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15:426–44.
   PubMed Web of Science ®Google Scholar
• Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF. Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest. 2003;112:717–24.
   PubMed Web of Science ®Google Scholar
• Prasad K, Koob R. Cardiovascular function in dogs with acute hypokalemia. Angiology. 1978;29:589–600.
   PubMed Web of Science ®Google Scholar
• Severi S, Grandi E, Pes C, Badiali F, Grandi F, Santoro A. Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: in vivo and in silico analysis. Nephrol Dial Transplant. 2008;23:1378–86.
   PubMed Web of Science ®Google Scholar
• Tabara Y, Takahashi Y, Kohara K, Setoh K, Kawaguchi T, Terao C, et al. Association of longer QT interval with arterial waveform and lower pulse pressure amplification: the Nagahama Study. Am J Hypertens. 2013;26:973–80.
   PubMed Web of Science ®Google Scholar